Our work gets us noticed. UBMD physicians make headlines for raising the bar on clinical care, leading community health initatives and conducting groundbreaking research, among other advancements and accomplishments.
UB's Alzheimer’s Disease and Memory Disorders Center is significantly expanding its geographic outreach to patients, families, caregivers and medical providers.
Keynote speaker Christopher St. Vil, PhD, advocated for CVI, which focuses on supporting the people who are at the highest risk of engaging in violence.
Jacobs School of Medicine and Biomedical Sciences medical students who were recipients of 2022 Fellowships in Social Justice, Equity Administration and Leadership presented their research findings at a symposium April 19.
The first genome-wide significant study of the epigenetics of age-related macular degeneration (AMD) has yielded a trove of genetic mechanisms and pathways that are responsible for this disease.
The first genome-wide significant study of the epigenetics of age-related macular degeneration (AMD) has yielded a trove of genetic mechanisms and pathways that are responsible for this disease.
A celebratory mood was evident as the Jacobs School of Medicine and Biomedical Sciences community gathered April 12 to recognize the winners and honorable mentions in the 2023 Louis A. and Ruth Siegel Awards for Excellence in Teaching.
A study led by University at Buffalo researchers has confirmed that contrary to claims by anti-vaccine proponents, COVID-19 vaccines pose only trivial risk of venous thromboembolism (VTE), or blood clots.
A study led by University at Buffalo researchers has confirmed that contrary to claims by anti-vaccine proponents, COVID-19 vaccines pose only trivial risk of venous thromboembolism (VTE), or blood clots.
The past few years have seen numerous advances in the understanding of how Type 1 diabetes develops and how to manage it, yet the global disease burden remains high.
